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Abstract 
Iron deprivation of HL-60 cells with deferoxamine B mesylate (DFO) induced apoptosis. DNA fragmentation became apparent with 10Wh M DFO 
after 48 h treatment. The apoptosis peak according to the DNA histogram on flow cytometory and typical nuclear collapse and were observed 
microscopically after 48 h treatment with low4 M DFO. Cells treated with 10e4 M DFO for as little as 24 h were shown to be committed to apoptosis, 
as chromatin condensation progressed gradually thereafter. 
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1. In~~uction 
Iron chelation has been shown to cause S-phase inhibi- 
tion of cell proliferation [l]. The iron chelating reagent, 
deferoxamine B mesylate (DFO) is reported to enter cells 
and remove iron from the intracellular pool [2]. Since 
iron is essential for the activity of ribonucleotide reduc- 
tase, which is responsible for the synthesis of deoxyribo- 
nucleotides, cell growth was inhibited after DFO treat- 
ment [1,3]. Recently we reported that intracellular iron 
deprivation caused by DFO treatment increased the ex- 
pression of c-myc and c-fos protooncogenes in coordina- 
tion with the growth arrest of cells in the S phase [4-6]. 
The expression rates of c-fos and c-myc were shown to 
be enhanced after growth stimulation by serum, growth 
factor, 12-O-tetradecanoyl phorbol-13-acetate, or after 
induction of cell apoptosis [lo]. Also, overexpression of 
c-myc was shown to induce apoptosis [l 11. In the present 
report we show apoptosis may be induced by DFO treat- 
ment. 
2. Materials and Methods 
2.1. Ceils 
Human myloblastic leukemia cell line, HL-60 (supplied by JCRB), 
were cultured in RPM1 1640 supplemented with 10% heat-inactivated 
fetal bovine serum and 100 units/ml penicillin. Experiments were per- 
formed with exponentially growing cells at 3-6 x IO’ cells/ml. 
2.2. Reagents 
Deferoxamine B mesylate (DFO, M, 656.8 Ciba-Geigy, Base], Swit- 
zerland) was diluted into the culture medium immediately before use. 
2.3. DNA extraction and gel electrophoresjs 
Cells were lysed in guanidine-isothiocyanate nd DNA was extracted 
by benzyl chloride using the SepaGene kit (Sanko, Tokyo). After any 
remaining RNA was digested with 1 &ml RNaseA, 50 fig of each 
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DNA sample was loaded on to a 1.8% agarose gel. The gel was stained 
with ethidium bromide and photographed under UV illumination. 
2.4. Flow cytometry 
The cells were fixed in 50% ethanol, treated with 0.1 mglml RNase 
A, and stained with lOO&ml propidium iodide. Cell cycle profiles and 
distributions were determined by flow cytometry, FACScan (Be&on 
Dickinson, CA). 
2.5. Microscopic analysis 
Cells were cytocentrifuged and stained by the Papanicolau method. 
3. Results 
3.1. DNA fragmentation 
HL-60 cells were treated with 10w6, IO-’ and 10e4 M 
DFO for 24,48 or 72 h. Fig. 1 shows the electrophoresis 
pattern of cellular DNA after treatment with DFO. 
DNA fragmentation became apparent within 48 h of 
10m6 M DFO treatment. This pattern was more pro- 
nounced following treatment at lo-’ or 10V4 M and with 
longer incubation times (Fig. 1). To evaluate that the 
effect was due to the iron deprivation with DFO, we 
preincubated DFO with equal amount of FeCl,. The iron 
loaded DFO did not cause the DNA fragmentation (data 
not shown). 
3.2. PI staining pattern 
Fig. 2 demonstrates the DNA histograms of DFO- 
treated cells. With 3 x lo-’ M DFO treatment for 24 h, 
the accumulation of cells in the early S phase was ob- 
served (Fig. 2). With 48 h, 1O-4 M DFO treatment, the 
typical apoptosis pattern of cells containing a small 
amount of DNA, was demonstrated with a pronounced 
loss of cells in the S and G2M phase (Fig. 2). 
3.3. Microscopic analysis 
To examine the chromatin structure in detail, we em- 
ployed the Papanicolau staining method. The abnormal 
chromatin clumps and nuclear membrane wrinkling had 
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Fig. 1. DNA fragmentation analysis after deferoxamine treatment. Fifty pg of cellular DNA was electrophoresed on a 1.8% agarose gel. Similar 
findings were obtained in three separate experiments 
appeared after 24 h treatment with lo-’ M and 1O-4 M 
DFO (Fig. 3). Nuclear collapse appeared after 48 h treat- 
ment with 10m4 M DFO (Fig. 3). 
3.4. Determination of the period of DFO treatment for 
commitment to apoptosis 
We tried to determine the period of treatment required 
for DFO-induced apoptosis. After cells were treated for 
6, 12 or 24 h with 10m4 M DFO, the DFO-containing 
medium was replaced with fresh medium. Cells were 
cultured further for a total of 48 h, and their DNA 
histogram were studied. As shown in Fig. 4a, loss of 
G2M phase cells apparent after a 6 h treatment; how- 
ever, no apoptosis peak was observed after 24 h treat- 
ment. The apoptosis peak became apparent when cells 
treated with 10m4 M DFO for 24 h were cultured further 
with fresh medium for 24 h (Fig. 4b). Thus the cells were 
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committed to apoptosis after they had been exposed to 
DFO for at least 24 h. 
4. Discussion 
We have demonstrated that the DFO treatment 
caused the inhibition of cell growth and induced apopto- 
sis manifested as DNA fragmentation on electrophoresis 
and on DNA histogram and microscopic analyses. We 
observed recently that c-myc and c-fos expression rates 
increase after treatment with DFO, and felt this repre- 
sented the process of apoptosis [4-61. Increase of c-myc 
and c-fos expression preceding apoptosis was reported 
by several investigators and our results concur [7-lo]. 
Apoptosis caused by iron deprivation was mod- 
erate compared to that caused by various antitumor 
lo-5M 3x10-5M 1 O-%/j 
Non treat 1 O-GM IO-5M 3x10-5M lo-4M 
Fig. 2. DNA histograms of deferoxamine-treated cells. DNA histograms were analyzed after staining with propidium iodide, as described in section 
2. (a) 24 h treatment; (b) 48 h treatment. Arrow indicates the apoptosis peak after 48 h treatment of cells with IO-4 M DFO. Similar findings were 
obtained in three separate experiments. 
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Fig. 3. Microscopic analysis of deferoxamine-treated cells. Cells were 
stained by the Papanicolau method. Scale bar=10 pm. Similar findings 
were obtained in three separate experiments. 
agents [12]. We presume that the response to DFO was 
more moderate due to the fact DFO treatment did not 
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damage DNA directly. Iron chelation deactivates ribo- 
nucleotide reductase, perturbs the nucleotide pool, and 
thereby inhibits DNA synthesis. 
DNA fragmentation becomes evident prior to any 
change in the DNA frequency histogram or apparent 
change in chromatin structure. This result confirmed 
that the DNA cleavage was an early event leading to 
apoptosis in this system. 
Iron deprivation caused by low4 M DFO treatment for 
24 h may commit cells to apoptosis. Thereafter, typical 
apoptosis bodies formed gradually even in a medium 
without DFO. Due to the pace of this apoptosis being 
moderate, we would be able to analyze the mechanism 
of chromatin condensation process. 
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